Kaviyaprabha R, R K, Miji T, Tv M, Suseela R, R S
Curr Cancer Drug Targets. 2024; 25(2):183-203.
PMID: 39289946
DOI: 10.2174/0115680096321287240826065718.
Hasani F, Masrour M, Jazi K, Ahmadi P, Hosseini S, Lu V
Front Neurol. 2024; 15:1357321.
PMID: 38487328
PMC: 10937740.
DOI: 10.3389/fneur.2024.1357321.
Aroosa M, Malik J, Ahmed S, Bender O, Ahemad N, Anwar S
Mol Biol Rep. 2023; 50(9):7667-7680.
PMID: 37418080
PMC: 10460753.
DOI: 10.1007/s11033-023-08568-1.
Bora Yildiz C, Zimmer-Bensch G
Adv Exp Med Biol. 2022; 1389:363-394.
PMID: 36350518
DOI: 10.1007/978-3-031-11454-0_15.
Sufianov A, Begliarzade S, Ilyasova T, Liang Y, Beylerli O
Noncoding RNA Res. 2022; 7(3):171-177.
PMID: 35846075
PMC: 9271693.
DOI: 10.1016/j.ncrna.2022.07.001.
Combination Therapy with PIK3R3-siRNA and EGFR-TKI Erlotinib Synergistically Suppresses Glioblastoma Cell Growth In Vitro.
Amini R, Karami H, Bayat M
Asian Pac J Cancer Prev. 2021; 22(12):3993-4000.
PMID: 34967581
PMC: 9080388.
DOI: 10.31557/APJCP.2021.22.12.3993.
Unique Interplay Between Molecular miR-181b/d Biomarkers and Health Related Quality of Life Score in the Predictive Glioma Models.
Stakaitis R, Pranckeviciene A, Steponaitis G, Tamasauskas A, Bunevicius A, Vaitkiene P
Int J Mol Sci. 2020; 21(20).
PMID: 33050332
PMC: 7589546.
DOI: 10.3390/ijms21207450.
MicroRNA-585 inhibits human glioma cell proliferation by directly targeting MDM2.
Chen W, Hong L, Hou C, Wang Y, Wang F, Zhang J
Cancer Cell Int. 2020; 20:469.
PMID: 33005102
PMC: 7523344.
DOI: 10.1186/s12935-020-01528-w.
MiRNA-7 Replacement Effect on Proliferation and Tarceva-Sensitivity in U373-MG Cell Line.
Alamdari-Palangi V, Karami Z, Karami H, Baazm M
Asian Pac J Cancer Prev. 2020; 21(6):1747-1753.
PMID: 32592373
PMC: 7568905.
DOI: 10.31557/APJCP.2020.21.6.1747.
microRNAs and Markers of Neutrophil Activation as Predictors of Early Incidental Post-Surgical Pulmonary Embolism in Patients with Intracranial Tumors.
Oto J, Plana E, Solmoirago M, Fernandez-Pardo A, Hervas D, Cana F
Cancers (Basel). 2020; 12(6).
PMID: 32545233
PMC: 7353032.
DOI: 10.3390/cancers12061536.
Decreased expression of miR-410-3p correlates with poor prognosis and tumorigenesis in human glioma.
Wang C, Huang S, Rao S, Hu J, Zhang Y, Luo J
Cancer Manag Res. 2020; 11:10581-10592.
PMID: 31908530
PMC: 6927686.
DOI: 10.2147/CMAR.S202247.
Artificial microenvironment of in vitro glioblastoma cell cultures changes profile of miRNAs related to tumor drug resistance.
Witusik-Perkowska M, Zakrzewska M, Jaskolski D, Liberski P, Szemraj J
Onco Targets Ther. 2019; 12:3905-3918.
PMID: 31190889
PMC: 6535444.
DOI: 10.2147/OTT.S190601.
LINC00470 Coordinates the Epigenetic Regulation of ELFN2 to Distract GBM Cell Autophagy.
Liu C, Fu H, Liu X, Lei Q, Zhang Y, She X
Mol Ther. 2018; 26(9):2267-2281.
PMID: 30037656
PMC: 6127511.
DOI: 10.1016/j.ymthe.2018.06.019.
MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human glioma.
Sun S, Wang X, Xu X, Di H, Du J, Xu B
Oncotarget. 2016; 8(3):5057-5068.
PMID: 27926502
PMC: 5354892.
DOI: 10.18632/oncotarget.13789.
Effect of rs11614913 Polymorphism on Mature miR196a2 Expression and its Target Gene HOXC8 Expression in Human Glioma.
Sibin M, Harshitha S, Narasingarao K, Dhananjaya I, Dhaval P, Chetan G
J Mol Neurosci. 2016; 61(2):144-151.
PMID: 27796868
DOI: 10.1007/s12031-016-0855-z.
MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy.
Hong M, Wang N, Tan H, Tsao S, Feng Y
Cancers (Basel). 2015; 7(3):1643-57.
PMID: 26305257
PMC: 4586788.
DOI: 10.3390/cancers7030855.
Associations between SOX2 and miR-200b expression with the clinicopathological characteristics and prognosis of patients with glioma.
Wang B, Li M, Wu Z, Li X, Li Y, Shi X
Exp Ther Med. 2015; 10(1):88-96.
PMID: 26170917
PMC: 4486882.
DOI: 10.3892/etm.2015.2488.
MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.
Cheng Z, Wang H, Li X, Wu Z, Han Y, Li Y
J Exp Clin Cancer Res. 2015; 34:27.
PMID: 25888093
PMC: 4387599.
DOI: 10.1186/s13046-015-0142-9.
The challenges and the promise of molecular targeted therapy in malignant gliomas.
Wang H, Xu T, Jiang Y, Xu H, Yan Y, Fu D
Neoplasia. 2015; 17(3):239-55.
PMID: 25810009
PMC: 4372648.
DOI: 10.1016/j.neo.2015.02.002.
Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma.
Lai N, Wu D, Fang X, Lin Y, Chen S, Li Z
Br J Cancer. 2015; 112(7):1241-6.
PMID: 25756397
PMC: 4385967.
DOI: 10.1038/bjc.2015.91.